| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064438 Heteromeric variable regions with unvaried human framework regions |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064403 Novel Genes Encoding Novel Proteolytic Enzymes |
| 03/24/2005 | US20050064390 Transgenic cell line expressing chemokine receptor for use as model in identifying modulators wich prevent/block viral infection; viricides |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063976 Combination therapy for treating disease |
| 03/24/2005 | US20050063975 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents |
| 03/24/2005 | US20050063973 An antibody that binds specifically to TMF/ARA160 protein; receptor binding assay; gene expression inhibition of Fer using RNA interference; drug screening; prostate cancer |
| 03/24/2005 | US20050063972 via ion exchange chromatography via changing the conductivity and/or pH of buffers; humanized antibodies and acidic variants |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | US20050063967 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 03/24/2005 | CA2538895A1 Factor ixa specific antibodies displaying factor viiia like activity |
| 03/24/2005 | CA2538763A1 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | CA2538528A1 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | CA2538229A1 Treatment of rheumatoid arthritis with cd99 antagonists |
| 03/24/2005 | CA2538220A1 Use of antibody |
| 03/24/2005 | CA2538076A1 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | CA2537489A1 Vaccines |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | CA2537360A1 Methods and compositions for treating herpes infections |
| 03/24/2005 | CA2537217A1 Therapeutic binding molecules |
| 03/24/2005 | CA2536989A1 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | CA2536396A1 Methods of using wisp antagonists |
| 03/24/2005 | CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516929A2 Method for linking sequences of interest |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516630A2 Use of anti-il-12 antibodies in transplantation rejection |
| 03/23/2005 | EP1516629A2 Humanized anti CD-11a antibodies |
| 03/23/2005 | EP1516274A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516047A1 Purified pkb ser 473 kinase and uses thereof |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 03/23/2005 | EP1515747A2 Immunogenic agent therapy using plasmapheresis or exchange transfusion |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases |
| 03/23/2005 | EP1401871B1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 03/23/2005 | EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules |
| 03/23/2005 | EP0939813B1 Breast carcinoma-associated gene |
| 03/23/2005 | EP0845005B1 Traf inhibitors |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0662092B1 Activity-dependent neurotrophic factor |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599867A Immunocytokines with modulated selectivity |
| 03/23/2005 | CN1599755A Antibodies against caspase-8, their preparation and use |
| 03/23/2005 | CN1599754A Anti-TRAIL-R antibodies |
| 03/23/2005 | CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599624A Antibodies for inhibiting blood coagulation and methods of use thereof |
| 03/23/2005 | CN1597988A Human sel-10 polypeptides and polynucleotides that encode them |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597950A Icam-4 materials and methods |
| 03/23/2005 | CN1597945A Extracting norfibroase from snake venom and preparation process for liquid drugs injection of norfibroase |
| 03/23/2005 | CN1597694A Meningococcal antigens |
| 03/23/2005 | CN1596985A New clinical parameters for determining haematics toxicity prior to radioimmunotherapy |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1194089C large wasp sedative peptide precursor gene and its coded polypeptide and preparation |
| 03/23/2005 | CN1194017C Novel antibody, renin-active substance containing same and prorenin assay reagent using the same |
| 03/23/2005 | CN1194016C New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 03/23/2005 | CN1194012C Sperm formation relative protein and its coding sequence and use |
| 03/23/2005 | CN1194011C Preparation method and use of cobra Short-chain nervous cobratoxin |
| 03/23/2005 | CN1194010C Human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6870034 Protein purification |
| 03/22/2005 | US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 03/22/2005 | US6870032 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6870029 Method of diagnosing and treating gliomas |
| 03/22/2005 | US6869801 Assessment of cervical cells |
| 03/22/2005 | US6869790 Preparation of DNA encoding factor XIIIA |
| 03/22/2005 | US6869787 Which lack N-glycosidase-rRNA activity; kits |
| 03/22/2005 | US6869760 Use of prostate tumor inducing gene for detection of cancer cells |
| 03/22/2005 | US6869608 Peptides derived from a retrovirus of the HIV group and their use |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2134761C Synthetic peptide vaccines for dental caries |
| 03/22/2005 | CA2103059C Method for making humanized antibodies |
| 03/19/2005 | CA2441653A1 Targeted ligands |
| 03/17/2005 | WO2005024032A2 Targeting adenoviral vectors to dendritic cells |
| 03/17/2005 | WO2005024030A1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences |
| 03/17/2005 | WO2005024023A1 Brain tumor marker and method of diagnosing brain tumor |
| 03/17/2005 | WO2005024015A1 Expression vector |
| 03/17/2005 | WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 03/17/2005 | WO2005023993A2 Methods and compositions for generation of germline human antibody genes |
| 03/17/2005 | WO2005023980A2 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 03/17/2005 | WO2005023872A1 Antibodies against interleukin-1 receptor and uses thereof |
| 03/17/2005 | WO2005023871A1 An agent for selective suppression disease-associated auto-reactive b-cells |
| 03/17/2005 | WO2005023869A1 Antibody specifically binding to sulfonylated protein and method for producing the same |
| 03/17/2005 | WO2005023867A1 Method for the treatment or prophylaxis of tuberculosis |
| 03/17/2005 | WO2005023865A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 03/17/2005 | WO2005023864A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 03/17/2005 | WO2005023856A2 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 03/17/2005 | WO2005023849A2 Antigenic peptides of rabies virus and uses thereof |
| 03/17/2005 | WO2005023848A2 Adenoviral epitopes |